期刊文献+

肝样腺癌的临床特征和预后影响因素:基于SEER数据库的研究 被引量:4

The clinicopathological features and prognostic factors of hepatoid adenocarcinoma:a SEER population-based study
下载PDF
导出
摘要 目的探讨肝样腺癌的临床特征和预后的影响因素。方法研究对象来自于美国国立癌症研究所数据库(Surveillance,Epidemiology and End Result database,SEER数据库)的肝样腺癌病例。分析患者的基本临床特征和预后影响因素。主要结局是总生存期(overall survival,OS),次要结局是癌症特异性生存期(cancer specific survival,CSS)。结果共有139例肝样腺癌患者被纳入研究。肝样腺癌主要分布在男性(55.4%)、老年人(62.8%)、肺部(41.7%)和消化系统(39.6%)。所有患者的中位生存时间为4个月。1年和3年的OS和CSS分别为32.9%、36.1%和14.7%、17.3%。多变量分析显示远处转移(HR=2.477,95%CI:1.091~5.622,P=0.030),高T分期(T_(2),HR=4.444,95%CI:1.014~19.466,P=0.048;T_(4),HR=3.341,95%CI:1.007~11.080,P=0.049)是OS不良的独立影响因素,而原发部位手术治疗(HR=0.580,95%CI:0.345~0.975,P=0.040)是OS的独立保护性因素。此外,高T分期(T_(2),HR=8.058,95%CI:1.645~39.481,P=0.01;T_(4),HR=4.022,95%CI:1.052~15.375,P=0.042)是CSS的独立危险因素,而原发部位手术治疗(HR=0.556,95%CI:0.322~0.960,P=0.035)是CSS的独立保护因素。结论肝样腺癌在老年人、男性、肺部和消化系统中更为常见。高T分期、远处转移和手术治疗是影响预后的独立因素。 Objective To explore the clinical and prognostic characteristics of hepatoid adenocarcinoma(HAC).Methods HAC cases from SEER databases were included in the study.The basic clinical characteristics and prognosis of the patients were analyzed.The primary outcome was overall survival(OS),and the secondary outcome was cancer-specific survival(CSS).Results A total of 139 HAC patients were eventually included in the study.Generally,HAC is mainly distributed in the males(55.4%),elderly(62.8%),lungs(41.7%)and digestive system(39.6%).All patients had a median survival time of 4 months.Specifically,the OS and CSS at 1 and 3 years were 32.9%,36.1%,14.7%,and 17.3%,respectively.Multivariate analysis showed distant metastasis(HR=2.477,95%CI:1.091-5.622,P=0.030),advanced T stage(T_(2),HR=4.444,95%CI:1.014-19.466,P=0.048;T_(4),HR=3.341,95%CI:1.007-11.080,P=0.049)were independent risk factors for poor OS,while primary site surgery(HR=0.580,95%CI:0.345-0.975,P=0.040)was protective factor of OS.In addition,advanced T stage(T_(2),HR=8.058,95%CI:1.645-39.481,P=0.01;T_(4),HR=4.022,95%CI:1.052-15.375,P=0.042)was independent unfavorable factor of CSS,while primary site surgery(HR=0.556,95%CI:0.322-0.960,P=0.035)was a favorable one.Conclusion HAC is more common in the elderly,males,lungs,and digestive system.Advanced T stage,distant metastasis,and surgical treatment are independent factors for prognosis.
作者 张晓杰 赵东兵 Zhang Xiaojie;Zhao Dongbing(Department of Pancreatic and Gastric Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处 《消化肿瘤杂志(电子版)》 2021年第1期47-52,共6页 Journal of Digestive Oncology(Electronic Version)
关键词 肝样腺癌 SEER数据库 预后 Hepatoid adenocarcinoma Surveillance,Epidemiology,and End Results Prognosis
  • 相关文献

参考文献2

二级参考文献17

  • 1杨春康,赵文锦,戴起宝,张惠灏,郑炜.胃肝样腺癌临床特点及诊治分析[J].中华胃肠外科杂志,2007,10(3):245-248. 被引量:9
  • 2H. Gakiopoulou,N. Givalos,G. Liapis,G. Agrogiannis,E. Patsouris,I. Delladetsima.Hepatoid Adenocarcinoma of the Gallbladder[J].Digestive Diseases and Sciences.2007(12)
  • 3A. Lopez-Beltran,R. J. Luque,A. Quintero,M. J. Requena,R. Montironi.Hepatoid adenocarcinoma of the urinary bladder[J].Virchows Archiv.2003(4)
  • 4G. Bombski,A. Gasiorowska,D. Orszulak-Michalak,B. Neneman,J. Kotynia,J. Strzelczyk,A. Janiak,E. Malecka-Panas.Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection[J].International Journal of Colorectal Disease.2003(2)
  • 5Satoshi Inagawa,Jiro Shimazaki,Masao Hori,Fuyo Yoshimi,Shinya Adachi,Toru Kawamoto,Katashi Fukao,Masayuki Itabashi.Hepatoid adenocarcinoma of the stomach[J].Gastric Cancer.2001(1)
  • 6Z. Fan,M. Rijin,K. Montogomery,R.V. Rouse.Hep Par1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections[].Modern Pathology.2003
  • 7Porcell AI,De —Young BR,ProcaDM,et al.Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver:MOC31 compares favorably with other putative markers[].Modern Pathology.2000
  • 8F Naghibalhossaini,P Ebadi.Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme[].Cancer Letters.2006
  • 9MJ Lee,HS Lee,WH Kim,Y Choi,MH Yang.Expression of mucins and cytokeratins in primary carcinomas of the digestive system[].Modern Pathology.2003
  • 10Lau SK,Prakash S,Geller SA,Alsabeh R.Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma[].Human Pathology.2002

共引文献103

同被引文献38

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部